scholarly journals Vasopressin for treatment of hemodynamic disorders

Medicina ◽  
2008 ◽  
Vol 44 (2) ◽  
pp. 167
Author(s):  
Dalia Adukauskienë ◽  
Edmundas Ðirvinskas ◽  
Egidijus Këvelaitis

Vasopressin is a 9-amino acid peptide synthesized by magnocellular neurons of the hypothalamus and released from posterior pituitary gland. The primary physiological role of vasopressin is the maintenance of fluid homeostasis. In this review, the classification of vasopressin receptors, namely V1 vascular, V2 renal, V3 pituitary, oxytocin receptors, and purinergic receptors, and the effects of vasopressin on vascular smooth muscles, the heart, and the kidneys are discussed. Mortality rates of vasodilatory (or distributive), for example septic shock, are high. The use of vasopressin is an alternative therapy for vasodilatory shock with better outcome. Vasopressin is effective in resuscitation of adults after ventricular fibrillation or pulseless tachycardia, when epinephrine is not effective.

1979 ◽  
Vol 57 (2) ◽  
pp. 129-139 ◽  
Author(s):  
D. Regoli

Angiotensin exerts numerous contractile and secretory effects by activating specific receptors. Recent pharmacological findings obtained with this peptide in various laboratories are analyzed, using the order of potency of agonists and the affinity of competitive antagonists as criteria for the classification of receptors for angiotensin in several systems. The analysis is restricted to experiments in which biological effects have been measured. Desensitization (the third criterion for classification of receptors) is discussed and a new protocol is proposed for its utilization.The analysis reveals that receptors for angiotensin in intestinal and vascular smooth muscles, in the heart, and in the vas deferens are all of the same type, while the receptors mediating the release of catecholamines from the adrenal medulla and those subserving the steroidogenic action on the adrenal cortex remain still unidentified.The recently proposed role of ATI as mediator of renin in the adrenal medulla is not substantiated by pharmacological findings with decapeptide antagonists. Moreover, the utilization of ATI as an agonist to determine the order of potency of angiotensins and the use of SQ 20881 as an inhibitor of the converting enzyme have shown serious limitations and should be reconsidered.The hypothetical role of ATIII as mediator of the renin–angiotensin system in the adrenal cortex, at least in other species than the rat, appears to be supported by the high affinity of heptapeptide antagonists for the adrenocortical receptor. However, these antagonists have generally been compared with [Sar1,Ala8]-ATII, a compound which is definitely inadequate for evaluating the affinities of octapeptides in the adrenal cortex. Therefore most of the data supporting the role of ATIII in this system have to be carefully reconsidered.Analogues of ATII are proposed for using as agonists and as antagonists instead of the natural angiotensins (for determining the order of potency of agonists) and instead of [Sar1,Ala8]-ATII (for measuring the affinities of competitive antagonists).


2010 ◽  
Vol 108 (3) ◽  
pp. 544-553 ◽  
Author(s):  
Atheer M. Almasri ◽  
Paul H. Ratz ◽  
Hersch Bhatia ◽  
Adam P. Klausner ◽  
John E. Speich

The length-tension ( L-T) relationships in airway and vascular smooth muscles have been shown to adapt with length changes over time. Our prior studies have shown that the active and passive L-T relationships in rabbit detrusor smooth muscle (DSM) can adapt and that DSM exhibits adjustable passive stiffness (APS) characterized by a passive L-T curve that is a function of strain and activation history. The present study demonstrates that passive tension due to APS can represent a substantial fraction of total tension over a broad length range. Our previous studies have shown that maximal KCl-induced contractions at short muscle lengths generate APS that is revealed by increased pseudo-steady-state passive tension at longer lengths compared with previous measurements at those lengths. The objective of the present study was to determine the mechanisms involved in APS generation. Increasing the number of KCl-induced contractions or the duration of a contraction increased the amount of APS generated. Furthermore, a fraction of APS was restored in calcium-free solution and was sensitive to the general serine and threonine protein kinase inhibitor staurosporine. Most importantly, rhythmic contraction (RC) generated APS, and because RC occurs spontaneously in human bladder, a physiological role for RC was potentially identified.


1982 ◽  
Vol 60 (12) ◽  
pp. 1580-1583 ◽  
Author(s):  
D. Regoli ◽  
J. Mizrahi ◽  
P. D'Orléans-Juste ◽  
S. Caranikas

Bradykinin (BK) and des-Arg9-BK were used to determine whether the stimulatory and inhibitory actions of the kinins in various isolated vessels require the presence of endothelium and may be mediated by arachidonic acid metabolites. It was found that the presence of intact endothelium is required only for the relaxation of the dog common carotid artery in response to bradykinin. Stimulatory actions of both BK and des-Arg9-BK in arterial (rabbit aorta) and venous (rabbit jugular and mesenteric vein) smooth muscle do not require the presence of endothelium. Inhibition of the arachidonic acid cascade at various levels affects the relaxing action of acetylcholine (rabbit aorta and dog common carotid artery) while being inactive against both the relaxing (dog common carotid artery) and contractile actions (rabbit aorta, rabbit jugular and mesenteric veins) of bradykinin and des-Arg9-BK. Inhibitors of the arachidonic acid cascade also do not affect the inhibitory action of isopropylnoradrenaline on the rabbit aorta. The present results indicate that stimulant actions of kinins in isolated vascular smooth muscles do not require the presence of endothelium. Endothelium is required for the inhibitory actions of acetylcholine and bradykinin but not for that of isopropylnoradrenaline on the dog carotid artery. Moreover, the inhibition of arachidonic acid metabolism only affects the response of isolated vessels to acetylcholine. The present results suggest that several mechanisms may be involved in the inhibition of vascular tone by vasodilators.


2008 ◽  
Vol 74 (20) ◽  
pp. 6271-6279 ◽  
Author(s):  
Mary O'Connell Motherway ◽  
Gerald F. Fitzgerald ◽  
Sabine Neirynck ◽  
Sinead Ryan ◽  
Lothar Steidler ◽  
...  

ABSTRACT The apuB gene of Bifidobacterium breve UCC2003 was shown to encode an extracellular amylopullulanase. ApuB is composed of a distinct N-terminally located α-amylase-containing domain which hydrolyzes α-1,4-glucosidic linkages in starch and related polysaccharides and a C-terminally located pullulanase-containing domain which hydrolyzes α-1,6 linkages in pullulan, allowing the classification of this enzyme as a bifunctional class II pullulanase. A knockout mutation of the apuB gene in B. breve UCC2003 rendered the resulting mutant incapable of growth in medium containing starch, amylopectin, glycogen, or pullulan as the sole carbon and energy source, confirming the crucial physiological role of this gene in starch metabolism.


The identity of organelles storing intracellular calcium and the role of Ins(1,4,5) P 3 , in muscle have been explored with, respectively, electron probe X-ray microanalysis (EPMA) and laser photolysis of ‘caged’ compounds. The participation of G-protein(s) in the release of intracellular Ca 2+ was determined in saponin-permeabilized smooth muscle. The sarcoplasmic reticulum (SR) is identified as the major source of activator Ca 2+ in both smooth and striated muscle; similar (EPMA) studies suggest that the endoplasmic reticulum is the major Ca 2+ storage site in non-muscle cells. In none of the cell types did mitochondria play a significant, physiological role in the regulation of cytoplasmic Ca 2+ . The latency of guinea pig portal vein smooth muscle contraction following photolytic release of phenylephrine, an α 1 -agonist, is 1.5 ± 0.26 s at 20 °C and 0.6 ± 0.18 s at 30 °C; the latency of contraction after photolytic release of Ins(1,4,5) P 3 from caged Ins(1,4,5) P 3 is 0.5 ± 0.12 s at 20 °C. The long latency of α 1 -adrenergic Ca 2+ release and its temperature dependence are consistent with a process mediated by G-protein-coupled activation of phosphatidylinositol 4,5 bisphosphate (PtdIns(4,5) P 2 ) hydrolysis. GTPγS, a non-hydrolysable analogue of GTP, causes Ca 2+ release and contraction in permeabilized smooth muscle. Ins(1,4,5) P 3 has an additive effect during the late, but not the early, phase of GTPγS action, and GTPγS can cause Ca 2+ release and contraction of permeabilized smooth muscles refractory to Ins(l,4,5) P 3 . These results suggest that activation of G protein (s) can release Ca 2+ by, at least, two G-proteinregulated mechanisms: one mediated by Ins(1,4,5) P 3 and the other Ins(1,4,5) P 3 - independent. The Ins(1,4,5) P 3 , 5-phosphatase activity and the slow time-course (seconds) of the contractile response toIns(1,4,5) P 3 released with laser flash photolysis from caged Ins(1,4,5) P 3 in frog skeletal muscle suggest that Ins(1,4,5) P 3 is unlikely to be the physiological messenger of excitation-contraction coupling of striated muscle. In contrast, in smooth muscle the high Ins Ins(1,4,5) P 3 -5-phosphatase activity and the rate of force development after photolytic release of Ins(1,4,5) P 3 are compatible with a physiological role of Ins(1,4,5) P 3 as a messenger of pharmacomechanical coupling.


Sign in / Sign up

Export Citation Format

Share Document